Transpara by ScreenPoint Medical at SBI Breast Imaging Symposium 2026
ScreenPoint Medical is excited to participate in the SBI Breast Imaging Symposium 2026, a premier event for breast imaging, taking place from April 16-19, 2026, in Seattle. Discover how Transpara has helped enhance workflow, confidence and results for national screening programs and renowned institutions.
Join us as we explore the role of AI in supporting radiologists in advancing patient care.
© 2025, ScreenPoint Medical BV. All rights reserved. Transpara® is a registered trademark of ScreenPoint Medical BV. Reproduction of any material contained herein in any format or media without express written permission of ScreenPoint Medical BV is prohibited. *Disclaimer: Transpara is CE marked and FDA cleared for 2D and 3D mammography. CE (0344) certified. FDA 510(k) K241831. Not all features are available in all countries. Please check with local representatives.
Lake Medical Imaging Case Study
Download the study to see how Transpara reduces radiologist workload and improves diagnostic confidence.
